Results 1 to 10 of about 27,396 (199)
Stages of health behavior change and factors associated with physical activity in patients with intermittent claudication [PDF]
OBJECTIVE: To analyze, in people with intermittent claudication, the frequency of individuals who are in each of stages of health behavior change to practice physical activity, and analyze the association of these stages with the walking capacity ...
Jacilene Guedes de Oliveira +7 more
doaj +4 more sources
Increasing walking in patients with intermittent claudication: Protocol for a randomised controlled trial [PDF]
Background People with intermittent claudication are at increased risk of death from heart attack and stroke compared to matched controls. Surgery for intermittent claudication is for symptom management and does not reduce the risk of cardiovascular ...
O'Carroll Ronan E +3 more
doaj +5 more sources
Remote ischemic preconditioning in patients with intermittent claudication [PDF]
OBJECTIVE: Remote ischemic preconditioning (RIPC) is a phenomenon in which a short period of sub-lethal ischemia in one organ protects against subsequent bouts of ischemia in another organ.
Glauco Fernandes Saes +9 more
doaj +6 more sources
Pentoxifylline for intermittent claudication [PDF]
Obliterating atherosclerosis of the lower extremities leading to a decrease in blood flow occurs in approximately 12% of the population. The pathology is most commonly manifested at the stage of intermittent claudication.
N. A. Vaulin
doaj +3 more sources
Examination of Lower Limb Microcirculation in Diabetic Patients with and without Intermittent Claudication [PDF]
Intermittent claudication is a frequent complaint in lower extremity artery disease, but approximately two thirds of patients are asymptomatic, most of which are diabetic patients. Non-invasive angiological and microrheological tests on diabetic subjects
Katalin Biró +8 more
doaj +2 more sources
Predictors of walking capacity in peripheral arterial disease patients [PDF]
OBJECTIVE: To estimate walking capacity in intermittent claudication patients through a prediction model based on clinical characteristics and the walking impairment questionnaire.
Breno Quintella Farah +7 more
doaj +4 more sources
Biomarker Analysis from the Compass Claudication Study – Rivaroxaban for Intermittent Claudication [PDF]
Introduction A prospective, randomized, multicenter study compared rivaroxaban 2.5 mg twice daily plus aspirin 100 mg once daily against aspirin 100 mg once daily alone in patients with peripheral artery disease and intermittent claudication.
Karen Falcão Britto MD +19 more
doaj +2 more sources
Intermittent claudication [PDF]
Intermittent claudication is the most common symptom in patients with peripheral arterial disease (PAD). As such, it is mandatory for clinicians to treat both the PAD-specific symptoms (to decrease functional impairment and thereby improve quality- of-life, as well as to decrease rates of amputation) and the underlying systemic atherosclerosis (and ...
Alan T., Hirsch, Laura, M Reich
openaire +2 more sources
Background Patients with intermittent claudication need lifelong treatment with secondary prevention to prevent cardiovascular events and progression of atherosclerotic disease.
Rebecka Striberger +3 more
doaj +1 more source
Objectives: It is challenging to accurately monitor the progress of intermittent claudication patients during or after treatment. Furthermore, diagnostic tools for intermittent claudication are not always adequate to determine whether other diseases are ...
Mark Greveling +6 more
doaj +1 more source

